OCULAR SAFETY OF HYDROXYCHLOROQUINE SULFATE (PLAQUENIL)

被引:26
作者
BERNSTEIN, HN [1 ]
机构
[1] WASHINGTON HOSP CTR,WASHINGTON NATL EYE CTR,WASHINGTON,DC 20010
关键词
D O I
10.1097/00007611-199203000-00010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Analysis of all published cases and Food and Drug Administration (FDA) reports of retinopathy attributed to hydroxychloroquine sulfate (Plaquenil) does not reveal any evidence of permanent visual field scotoma occurring when the daily dose is related to body weight and does not exceed 6.5 mg/kg for maintenance therapy. Risk factors of unknown degree may appear at this dosage level only when the duration of treatment exceeds 10 years or when chronic renal insufficiency is present. In the absence of risk factors, annual ophthalmologic examinations and central field testing are recommended because non-drug-related macular diseases commonly occur in the older age group. When risk factors are present, more frequent examinations are indicated. A modified Amsler grid screening test for the central 10-degrees of visual field is described and the participation of the treating physician in the testing program is encouraged to provide maximal medicolegal protection.
引用
收藏
页码:274 / 279
页数:6
相关论文
共 21 条
[1]  
BRAUNVALLON S, 1964, EENT DIG, V26, P32
[2]  
BRINKLEY JR, 1979, AM J OPHTHALMOL, V88, P1, DOI 10.1016/0002-9394(79)90743-8
[3]  
DOUCHE C, 1983, J FR OPHTALMOL, V6, P689
[4]   OCULAR EFFECTS AND SAFETY OF ANTIMALARIAL AGENTS [J].
EASTERBROOK, M .
AMERICAN JOURNAL OF MEDICINE, 1988, 85 (4A) :23-29
[5]  
FINBLOOM DS, 1985, J RHEUMATOL, V12, P692
[6]   SCREENING FOR ANTIMALARIAL MACULOPATHY IN RHEUMATOLOGY CLINICS [J].
FLECK, BW ;
BELL, AL ;
MITCHELL, JD ;
THOMSON, BJ ;
HURST, NP ;
NUKI, G .
BRITISH MEDICAL JOURNAL, 1985, 291 (6498) :782-785
[7]   STATIC PERIMETRY IN CHLOROQUINE RETINOPATHY - PERIFOVEAL PATTERNS OF VISUAL-FIELD DEPRESSION [J].
HART, WM ;
BURDE, RM ;
JOHNSTON, GP ;
DREWS, RC .
ARCHIVES OF OPHTHALMOLOGY, 1984, 102 (03) :377-380
[8]   HYDROXYCHLOROQUINE THERAPY IN MASSIVE TOTAL DOSES WITHOUT RETINAL TOXICITY [J].
JOHNSON, MW ;
VINE, AK .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1987, 104 (02) :139-144
[9]   DOSAGE OF ANTIMALARIAL DRUGS FOR CHILDREN WITH JUVENILE RHEUMATOID ARTHRITIS AND SYSTEMIC LUPUS ERYTHEMATOSUS - CLINICAL STUDY WITH DETERMINATION OF SERUM CONCENTRATIONS OF CHLOROQUINE AND HYDROXYCHLOROQUINE [J].
LAAKSONEN, AL ;
KOSKIAHDE, V ;
JUVA, K .
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 1974, 3 (02) :103-108
[10]   DOSE REFINEMENTS IN LONG-TERM THERAPY OF RHEUMATOID-ARTHRITIS WITH ANTI-MALARIALS [J].
MACKENZIE, AH .
AMERICAN JOURNAL OF MEDICINE, 1983, 75 (1A) :40-45